Contact Person : Daniel Bond; Last Date for the submission of abstract : 15-Apr-2019; Key Discussions on Biosimilars 2019Current regulatory status of biosimilar medicines in the EUMarket access and regulatory developmentsSustainability of the biosimilar medicines sectorAdvances and convergence of regulatory scienceRegulatory requirements, scientic and operational challenges